ShareValue scores for 000813.SHE: Valuation 52, Quality 28, Growth 47, Health 40.

000813.SHE
SZSE

Dezhan HealthCare Co Ltd

CN¥2.80(-2.78%)

Updated

Loading chart...
Sentiment

Pulse

Rating

Low

Trap Risk

P/E to median

Not enough data
Valuation
52
Fair Value

vs Shenzhen-listed Healthcare stocks

Price vs Value
Quality
28
Weak
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
40
Stressed
Financial Stability
Price trend
41
Neutral
Separate from the four scores

Company Details

About

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules. It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People's Republic of China.

Score Analysis

AI Investment Thesis

Data as of:Nov 13, 2026

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.